Outlook 2020: Regulatory trends and challenges

John Cleverley
Product Manager
Blaine Van Leuven
CMC Regulatory Director

Recent manufacturing advances have led the FDA to proclaim that continuous manufacturing is one of the important tools to modernize the pharma industry through its faster, more efficient processes. The move to continuous manufacturing involves more than just equipment and manufacturing processes. Regulatory compliance must also be considered. Get up to speed on the latest regulatory developments as we look forward to 2020. We’ll discuss key trends and changes in manufacturing that pharma companies should anticipate for a successful year.

To understand the future of continuous manufacturing in pharma, this presentation examines:

  • Batch vs continuous processing
  • The trends in adoption of continuous manufacturing
  • Regulatory views of continuous manufacturing
  • Navigating the implementation of continuous manufacturing in the current regulatory environment

Complete the form to the right to learn more!